Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021Matthew E. Oster, Tom T. Shimabukuro|JAMA|2022Cited by 670
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021Julia W. Gargano, Sara E. Oliver, Eric Weintraub et al.|MMWR Morbidity and Mortality Weekly Report|2021Cited by 602
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance studyIan Kracalik, Jacek M. Mazurek, Matthew E. Oster et al.|The Lancet Child & Adolescent Health|2022Cited by 78
Databases for Congenital Heart Defect Public Health Studies Across the LifespanTiffany Riehle‐Colarusso, Rachel Daskalov, Lisa Bergersen et al.|Journal of the American Heart Association|2016Cited by 33